Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study to Assess WATCHMAN FLX™ Implants by Cardiac Computed Tomography, Magnetic Resonance Imaging and Transesophageal Echocardiography: WATCHMAN FLX™ CT

NCT05324371 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT05324371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05324371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study to Assess WATCHMAN FLX™ Implants by Cardiac Computed Tomography, Magnetic Resonance Imaging and Transesophageal Echocardiography: WATCHMAN FLX™ CT
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Completed
Start date
November 9, 2022
Completion date
January 23, 2025
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

the focus of the study is to reduce the risk of stroke and life-threatening bleeding events in patients with non-valvular atrial fibrillation